Selskabets formål er at drive handel og industri samt efter bestyrelsens beslutning udøve enhver virksomhed i forbindelse hermed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | - | 2.2 mio. | 420.2 mio. | 295.7 mio. | 231 | |
CVR: 14605185
Secondary names: SCANBIOTEK A/S
Compared to 130 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Troels Zakarias Glahn Kristiansen joined as ADM. DIR.
Stefan Bødtker Michelsen left as director
Christian Lykkehus Sørensen joined the board
Companies in the same industry and area